{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:20:54Z","timestamp":1792801254869,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671597"],"award-info":[{"award-number":["81671597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271258"],"award-info":[{"award-number":["82271258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074538"],"award-info":[{"award-number":["82074538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-Level Local Universities in Shanghai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}]},{"name":"Development Project of Shanghai Peak Disciplines-Integrated Chinese and Western Medicine"},{"name":"Shanghai Key Laboratory for Acupuncture Mechanism and Acupoint Function","award":["21DZ2271800"],"award-info":[{"award-number":["21DZ2271800"]}],"id":[{"id":"https:\/\/ror.org\/01f1xbb18","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the central nervous system (CNS). Although studies have demonstrated that microglia facilitate remyelination in demyelinating diseases, the underlying mechanisms are still not fully characterized. We found that aryl hydrocarbon receptor (AhR), an environment sensor, was upregulated within the corpus callosum in the cuprizone model of CNS demyelination, and upregulated AhR was mainly confined to microglia. Deletion of AhR in adult microglia inhibited efficient remyelination. Transcriptome analysis using RNA-seq revealed that AhR-deficient microglia displayed impaired gene expression signatures associated with lysosome and phagocytotic pathways. Furthermore, AhR-deficient microglia showed impaired clearance of myelin debris and defected phagocytic capacity. Further investigation of target genes of AhR revealed that spleen tyrosine kinase (SYK) is the downstream effector of AhR and mediated the phagocytic capacity of microglia. Additionally, AhR deficiency in microglia aggravated CNS inflammation during demyelination. Altogether, our study highlights an essential role for AhR in microglial phagocytic function and suggests the therapeutic potential of AhR in demyelinating diseases.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12974-023-02764-3","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T11:02:54Z","timestamp":1679742174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Microglial aryl hydrocarbon receptor enhances phagocytic function via SYK and promotes remyelination in the cuprizone mouse model of demyelination"],"prefix":"10.1186","volume":"20","author":[{"given":"Yumeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"issue":"2","key":"2764_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","volume":"179","author":"M Prinz","year":"2019","unstructured":"Prinz M, Jung S, Priller J. Microglia biology: one century of evolving concepts. Cell. 2019;179(2):292\u2013311.","journal-title":"Cell"},{"key":"2764_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","volume":"39","author":"M Prinz","year":"2021","unstructured":"Prinz M, Masuda T, Wheeler MA, Quintana FJ. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu Rev Immunol. 2021;39:251\u201377.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"2764_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med. 2019;25(2):112\u201323.","journal-title":"Trends Mol Med"},{"issue":"1","key":"2764_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"8","key":"2764_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE. The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol. 2019;15(8):447\u201358.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2764_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1189\/jlb.3RI1116-494R","volume":"101","author":"VE Miron","year":"2017","unstructured":"Miron VE. Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination. J Leukoc Biol. 2017;101(5):1103\u20138.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2764_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018;378(2):169\u201380.","journal-title":"N Engl J Med"},{"issue":"1","key":"2764_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25\u201336.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2764_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol. 2014;10(4):225\u201338.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2764_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-017-0831-8","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, et al. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis. J Neuroinflammation. 2017;14(1):57.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"2764_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki C, Zalc B, Williams A, Stadelmann C, Stankoff B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 2020;19(8):678\u201388.","journal-title":"Lancet Neurol"},{"key":"2764_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.conb.2017.09.013","volume":"47","author":"AS Saab","year":"2017","unstructured":"Saab AS, Nave K-A. Myelin dynamics: protecting and shaping neuronal functions. Curr Opin Neurobiol. 2017;47:104\u201312.","journal-title":"Curr Opin Neurobiol"},{"key":"2764_CR13","doi-asserted-by":"crossref","unstructured":"Schirmer L, M\u00f6bius W, Zhao C, Cruz-Herranz A, Ben Haim L, Cordano C, et al. Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity. Elife. 2018;7.","DOI":"10.7554\/eLife.36428"},{"issue":"3","key":"2764_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer V, Quintana FJ. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol. 2019;19(3):184\u201397.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2764_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/ijms23010288","volume":"23","author":"AS Cannon","year":"2021","unstructured":"Cannon AS, Nagarkatti PS, Nagarkatti M. Targeting AhR as a novel therapeutic modality against inflammatory diseases. Int J Mol Sci. 2021;23(1):288.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2764_CR16","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/ijms19123851","volume":"19","author":"DR Neavin","year":"2018","unstructured":"Neavin DR, Liu D, Ray B, Weinshilboum RM. The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases. Int J Mol Sci. 2018;19(12):3851.","journal-title":"Int J Mol Sci"},{"key":"2764_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnana.2017.00004","volume":"11","author":"E Kimura","year":"2017","unstructured":"Kimura E, Tohyama C. Embryonic and postnatal expression of aryl hydrocarbon receptor mRNA in mouse brain. Front Neuroanat. 2017;11:4.","journal-title":"Front Neuroanat"},{"issue":"5","key":"2764_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/dneu.22330","volume":"76","author":"DP Dever","year":"2016","unstructured":"Dever DP, Adham ZO, Thompson B, Genestine M, Cherry J, Olschowka JA, et al. Aryl hydrocarbon receptor deletion in cerebellar granule neuron precursors impairs neurogenesis. Dev Neurobiol. 2016;76(5):533\u201350.","journal-title":"Dev Neurobiol"},{"issue":"3","key":"2764_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/jnc.12130","volume":"125","author":"SE Latchney","year":"2013","unstructured":"Latchney SE, Hein AM, O\u2019Banion MK, DiCicco-Bloom E, Opanashuk LA. Deletion or activation of the aryl hydrocarbon receptor alters adult hippocampal neurogenesis and contextual fear memory. J Neurochem. 2013;125(3):430\u201345.","journal-title":"J Neurochem"},{"issue":"6","key":"2764_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22(6):586\u201397.","journal-title":"Nat Med"},{"issue":"4","key":"2764_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000359","volume":"4","author":"V Rothhammer","year":"2017","unstructured":"Rothhammer V, Borucki DM, Garcia Sanchez MI, Mazzola MA, Hemond CC, Regev K, et al. Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS. Neurol Neuroimmunol Neuroinflamm. 2017;4(4): e359.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"2764_CR22","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1212\/NXI.0000000000000933","volume":"8","author":"T Tsaktanis","year":"2021","unstructured":"Tsaktanis T, Beyer T, Nirschl L, Linnerbauer M, Grummel V, Bussas M, et al. Aryl hydrocarbon receptor plasma agonist activity correlates with disease activity in progressive MS. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e933.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"2764_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103227","volume":"64","author":"P-X Shen","year":"2021","unstructured":"Shen P-X, Li X, Deng S-Y, Zhao L, Zhang Y-Y, Deng X, et al. Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor. EBioMedicine. 2021;64: 103227.","journal-title":"EBioMedicine"},{"issue":"1","key":"2764_CR24","doi-asserted-by":"publisher","first-page":"15963","DOI":"10.1038\/s41598-022-20164-0","volume":"12","author":"Y Jand","year":"2022","unstructured":"Jand Y, Ghahremani MH, Ghanbari A, Ejtemaei-Mehr S, Guillemin GJ, Ghazi-Khansari M. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway. Sci Rep. 2022;12(1):15963.","journal-title":"Sci Rep"},{"issue":"1","key":"2764_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12974-021-02193-0","volume":"18","author":"R-N Duan","year":"2021","unstructured":"Duan R-N, Yang C-L, Du T, Liu A, Wang A-R, Sun W-J, et al. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway. J Neuroinflammation. 2021;18(1):145.","journal-title":"J Neuroinflammation"},{"issue":"7707","key":"2764_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao C-C, Ardura-Fabregat A, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557(7707):724\u20138.","journal-title":"Nature"},{"key":"2764_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","volume":"107","author":"MK Sen","year":"2019","unstructured":"Sen MK, Mahns DA, Coorssen JR, Shortland PJ. Behavioural phenotypes in the cuprizone model of central nervous system demyelination. Neurosci Biobehav Rev. 2019;107:23\u201346.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"2764_CR28","first-page":"597","volume":"39","author":"SK Ludwin","year":"1978","unstructured":"Ludwin SK. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest. 1978;39(6):597\u2013612.","journal-title":"Lab Invest"},{"issue":"2","key":"2764_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O. Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol. 2019;17(2):129\u201341.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"2764_CR30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/cells9040843","volume":"9","author":"J Zhan","year":"2020","unstructured":"Zhan J, Mann T, Joost S, Behrangi N, Frank M, Kipp M. The cuprizone model: dos and do nots. Cells. 2020;9(4):843.","journal-title":"Cells"},{"issue":"8","key":"2764_CR31","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","volume":"211","author":"R Yamasaki","year":"2014","unstructured":"Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med. 2014;211(8):1533\u201349.","journal-title":"J Exp Med"},{"issue":"1","key":"2764_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s42003-021-01851-6","volume":"4","author":"T Illouz","year":"2021","unstructured":"Illouz T, Nicola R, Ben-Shushan L, Madar R, Biragyn A, Okun E. Maternal antibodies facilitate Amyloid-\u03b2 clearance by activating Fc-receptor-Syk-mediated phagocytosis. Commun Biol. 2021;4(1):329.","journal-title":"Commun Biol"},{"issue":"1","key":"2764_CR33","doi-asserted-by":"publisher","first-page":"22086","DOI":"10.1038\/s41598-020-79156-7","volume":"10","author":"H Tabata","year":"2020","unstructured":"Tabata H, Morita H, Kaji H, Tohyama K, Tohyama Y. Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling in complement-mediated phagocytosis. Sci Rep. 2020;10(1):22086.","journal-title":"Sci Rep"},{"issue":"10111","key":"2764_CR34","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017;390(10111):2481\u20139.","journal-title":"Lancet"},{"key":"2764_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2017.05.015","volume":"105","author":"AP Mullin","year":"2017","unstructured":"Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, et al. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Neurobiol Dis. 2017;105:142\u201355.","journal-title":"Neurobiol Dis"},{"issue":"24","key":"2764_CR36","doi-asserted-by":"publisher","first-page":"16182","DOI":"10.3390\/ijms232416182","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang D, Sun J, Wang Y, Wu S, Wang J. Huperzine-A improved animal behavior in cuprizone-induced mouse model by alleviating demyelination and neuroinflammation. Int J Mol Sci. 2022;23(24):16182.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2764_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41593-018-0290-2","volume":"22","author":"C B\u00f6ttcher","year":"2019","unstructured":"B\u00f6ttcher C, Schlickeiser S, Sneeboer MAM, Kunkel D, Knop A, Paza E, et al. Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry. Nat Neurosci. 2019;22(1):78\u201390.","journal-title":"Nat Neurosci"},{"issue":"2","key":"2764_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, Okamoto J, et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron. 2019;101(2):207.","journal-title":"Neuron"},{"issue":"9","key":"2764_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao J-W, Yuen TJ, Ruckh JM, Shadrach JL, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16(9):1211\u20138.","journal-title":"Nat Neurosci"},{"issue":"7","key":"2764_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154499","volume":"23","author":"K Zhu","year":"2022","unstructured":"Zhu K, Wang Y, Sarlus H, Geng K, Nutma E, Sun J, et al. Myeloid cell-specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation. EMBO Rep. 2022;23(7): e54499.","journal-title":"EMBO Rep"},{"key":"2764_CR41","doi-asserted-by":"crossref","unstructured":"Sun J-X, Zhu K-Y, Wang Y-M, Wang D-J, Zhang M-Z, Sarlus H, et al. Activation of TRPV1 receptor facilitates myelin repair following demyelination via the regulation of microglial function. Acta Pharmacol Sin. 2022.","DOI":"10.1038\/s41401-022-01000-7"},{"issue":"10","key":"2764_CR42","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","volume":"34","author":"K Shen","year":"2021","unstructured":"Shen K, Reichelt M, Kyauk RV, Ngu H, Shen Y-AA, Foreman O, et al. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep. 2021;34(10):108835.","journal-title":"Cell Rep"},{"issue":"4","key":"2764_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A, Larochelle A, Laflamme N, Pr\u00e9fontaine P, Plante M-M, S\u00e1nchez MG, et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med. 2015;212(4):481\u201395.","journal-title":"J Exp Med"},{"issue":"6","key":"2764_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nri2765","volume":"10","author":"A M\u00f3csai","year":"2010","unstructured":"M\u00f3csai A, Ruland J, Tybulewicz VLJ. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387\u2013402.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2764_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jb\/mvp001","volume":"145","author":"Y Tohyama","year":"2009","unstructured":"Tohyama Y, Yamamura H. Protein tyrosine kinase, syk: a key player in phagocytic cells. J Biochem. 2009;145(3):267\u201373.","journal-title":"J Biochem"},{"issue":"7","key":"2764_CR46","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/art.27438","volume":"62","author":"Z Jakus","year":"2010","unstructured":"Jakus Z, Simon E, Bal\u00e1zs B, M\u00f3csai A. Genetic deficiency of Syk protects mice from autoantibody-induced arthritis. Arthritis Rheum. 2010;62(7):1899\u2013910.","journal-title":"Arthritis Rheum"},{"issue":"14","key":"2764_CR47","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2008-07-166439","volume":"113","author":"A Podolanczuk","year":"2009","unstructured":"Podolanczuk A, Lazarus AH, Crow AR, Grossbard E, Bussel JB. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood. 2009;113(14):3154\u201360.","journal-title":"Blood"},{"issue":"22","key":"2764_CR48","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185(22):4135.","journal-title":"Cell"},{"issue":"22","key":"2764_CR49","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185(22):4153.","journal-title":"Cell"},{"key":"2764_CR50","doi-asserted-by":"crossref","unstructured":"Wei GZ, Martin KA, Xing PY, Agrawal R, Whiley L, Wood TK, et al. Tryptophan-metabolizing gut microbes regulate adult neurogenesis via the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2021;118(27).","DOI":"10.1073\/pnas.2021091118"},{"issue":"18","key":"2764_CR51","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1073\/pnas.1722124115","volume":"115","author":"J Fu","year":"2018","unstructured":"Fu J, Nogueira SV, Drongelen VV, Coit P, Ling S, Rosloniec EF, et al. Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc Natl Acad Sci U S A. 2018;115(18):4755\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2764_CR52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8 T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22(3):358\u201369.","journal-title":"Nat Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02764-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02764-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02764-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T11:23:00Z","timestamp":1702120980000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02764-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02764-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}